整合新型炎症反应参数评分的深静脉血栓形成后血栓后综合征预测模型构建
回顾性分析2018年1月至2022年1月承德医学院附属医院356例下肢深静脉血栓患者,随机按7:3分为训练集(249例)与验证集(107例),另37例外部验证。构建含NPM评分、分期、静脉曲张、同型半胱氨酸、规范抗凝治疗及一站式治疗的列线图模型。模型构建一致性指数0.918(95%CI 0.876-0.959),内部验证0.843(95%CI 0.741-0.945),外部验证0.823(95%CI 0.667-0.903)。
要点
- NPM评分由中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、单核细胞与高密度脂蛋白胆固醇比值组成,血栓后综合征组高于非血栓后综合征组(P<0.05)。
- 分期(OR=6.83,95%CI 2.74-18.04)、静脉曲张(OR=7.30,95%CI 2.29-25.75)、同型半胱氨酸(OR=1.12,95%CI 1.04-1.22)、NPM评分(OR=3.13,95%CI 1.94-5.36)、规范抗凝治疗(OR=5.77,95%CI 1.25-27.62)及一站式治疗(OR=0.04,95%CI 0.00-0.35)纳入列线图模型。
- 列线图模型在构建、内部验证和外部验证中均显示良好区分度与校准度,决策曲线分析显示预测血栓后综合征风险的概率阈值分别为3%-98%、5%-97%和10%-80%时具有更优净获益。
核心结论
- NPM评分联合分期、静脉曲张、同型半胱氨酸、规范抗凝治疗及一站式治疗的列线图模型,为卫生保健人员评估深静脉血栓患者血栓后综合征风险提供实用工具,有助于早期识别高危患者以有效预防血栓后综合征。
研究设计与样本
- 回顾性研究分析2018年1月至2022年1月承德医学院附属医院诊断为下肢深静脉血栓的患者,出院后6-24个月采用Villalta量表评估血栓后综合征发生情况。
- 患者按7:3随机分为训练集与验证集,训练集249例用于模型构建,验证集107例用于内部验证,另37例外部患者用于外部验证。
- 训练集对有意义的连续变量行单变量分析,差异有统计学意义的变量按最佳截断值转换为二分类变量,采用Log Lambda和最小绝对收缩和选择算子10折交叉验证进行变量选择,随后对所选变量行多变量逻辑回归分析构建模型。
- 模型在验证集行内部验证并在独立外部队列行外部验证,包括区分度分析、校准分析和临床决策曲线分析(DCA),最后评估模型合理性。
主要发现
- 共纳入356例下肢深静脉血栓患者,训练集249例用于模型构建,验证集107例用于内部验证,外部验证37例。
- 构建了包含中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和单核细胞与高密度脂蛋白胆固醇比值(MHR)的炎症反应参数复合评分(NLR-PLR-MHR评分,NPM评分),血栓后综合征组NPM评分显著高于非血栓后综合征组(P<0.05)。
- 与血栓后综合征发生风险相关的预测因素包括分期(OR=6.83,95%CI 2.74-18.04)、静脉曲张(OR=7.30,95%CI 2.29-25.75)、同型半胱氨酸(OR=1.12,95%CI 1.04-1.22)、NPM评分(OR=3.13,95%CI 1.94-5.36)、规范抗凝治疗(OR=5.77,95%CI 1.25-27.62)和一站式治疗(OR=0.04,95%CI 0.00-0.35),均纳入列线图模型。
- 模型区分度良好,一致性指数在模型构建为0.918(95%CI 0.876-0.959),内部验证为0.843(95%CI 0.741-0.945),外部验证为0.823(95%CI 0.667-0.903)。
- 列线图模型内部和外部验证校准曲线显示观察值与预测值吻合良好;DCA显示列线图模型预测血栓后综合征风险概率阈值在模型构建为3%-98%、内部验证为5%-97%、外部验证为10%-80%时,对预测血栓后综合征风险显示出更优净获益;合理性分析显示模型和内部验证较其他临床指标具有更高的区分度和临床净获益。
关键数值与推荐
- 列线图模型纳入的预测因素为:分期(OR=6.83,95%CI 2.74-18.04)、静脉曲张(OR=7.30,95%CI 2.29-25.75)、同型半胱氨酸(OR=1.12,95%CI 1.04-1.22)、NPM评分(OR=3.13,95%CI 1.94-5.36)、规范抗凝治疗(OR=5.77,95%CI 1.25-27.62)和一站式治疗(OR=0.04,95%CI 0.00-0.35)。
- 模型一致性指数:模型构建0.918(95%CI 0.876-0.959),内部验证0.843(95%CI 0.741-0.945),外部验证0.823(95%CI 0.667-0.903)。
- DCA预测血栓后综合征风险概率阈值:模型构建3%-98%,内部验证5%-97%,外部验证10%-80%。
临床怎么用
- 作者认为,NPM评分联合分期、静脉曲张、同型半胱氨酸、规范抗凝治疗及一站式治疗的列线图模型可为卫生保健人员评估深静脉血栓患者血栓后综合征风险提供实用工具,有助于早期识别高危患者以有效预防血栓后综合征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the independent predictive factors for post-thrombotic syndrome (PTS) and to construct a risk prediction model for PTS by incorporating a novel inflammatory response parameter (NPM score) scoring. METHODS: A retrospective study analyzed patients diagnosed with lower extremity deep vein thrombosis (LEDVTs at the Affiliated Hospital of Chengde Medical College from January 2018 to January 2022. The Villalta scale was used to assess the occurrence of PTS 6-24 months after discharge. Patients were randomly divided into a training set and a validation set at a ratio of 7:3. In the training set, univariate analysis was performed on meaningful continuous variables, and those with differences were converted into dichotomous variables based on optimal cutoff values. Variable selection was performed using Log Lambda and Least Absolute Shrinkage and Selection Operator 10-fold cross-validation, followed by multivariable logistic regression analysis on selected variables for model construction. The model underwent internal validation in the validation set and external validation in an independent external cohort, including discriminative analysis, calibration analysis, and clinical decision curve analysis (DCA), with the model's rationale being evaluated lastly. RESULTS: A total of 356 patients with lower extremity DVT were included, with 249 in the training set for model construction and 107 in the validation set for internal validation, along with 37 external patients for external validation. A composite score of inflammatory response parameters, including the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and monocyte to high-density lipoprotein cholesterol ratio (MHR) (NLR-PLR-MHR score, NPM score), was developed, showing a significantly higher NPM score in the PTS group compared to the non-PTS group (P < 0.05). Predictive factors related to the risk of PTS occurrence included staging (OR = 6.83, 95% CI: 2.74-18.04), varicose veins (OR = 7.30, 95% CI: 2.29-25.75), homocysteine (Hcy) (OR = 1.12, 95% CI: 1.04-1.22), NPM score (OR = 3.13, 95% CI: 1.94-5.36), standardized anticoagulant therapy (OR = 5.77, 95% CI: 1.25-27.62), and one-stop treatment (OR = 0.04, 95% CI: 0.00-0.35) were incorporated into the Nomogram model. The model showed good discrimination with a concordance index of 0.918 (95% CI: 0.876-0.959) for model construction, 0.843 (95% CI: 0.741-0.945) for internal validation, and 0.823 (95% CI: 0.667-0.903) for external validation. In the Nomogram model, internal and external validation calibration curves showed good agreement between observed and predicted values. DCA indicated that the Nomogram model predicted PTS risk probability thresholds ranging from 3% to 98% for model construction, 5%-97% for internal validation, and 10%-80% for external validation, demonstrating better net benefit for predicting PTS risk in the model, internal, and external validation. Rationality analysis showed the model and internal validation had higher discrimination and clinical net benefit than other clinical indices. CONCLUSIONS: The NPM score combined with stage, varicose veins, Hcy, standardized anticoagulant therapy, and one-stop treatment in the Nomogram model provides a practical tool for health care professionals to assess the risk of PTS in DVT patients, enabling early identification of high-risk patients for effective PTS prevention.
引用
- Huo J, Xiao Y, Liu S, et al. Construction of a Prediction Model for Post-thrombotic Syndrome after Deep Vein Thrombosis Incorporating Novel Inflammatory Response Parameter Scoring. Ann Vasc Surg. 2024. PMID: 38942364. doi:10.1016/j.avsg.2024.06.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。